📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease. (2017)

First Author: Jurynczyk M

Attributed to: University of Oxford Confidence in Concept Scheme – Round 4 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s40478-017-0495-8

PubMed Identifier: 29208041

Publication URI: http://europepmc.org/abstract/MED/29208041

Type: Journal Article/Review

Volume: 5

Parent Publication: Acta neuropathologica communications

Issue: 1

ISSN: 2051-5960